NDAs For Perinatal HIV Prevention May Refer To Foreign Data - Cmte.
Executive Summary
Foreign trial data will have to be acceptable to approve new drugs and new regimens for the prevention of perinatal transmission of HIV, FDA's Antiviral Drugs Advisory Committee concluded Oct. 4.